Health-related quality of life with adjuvant nivolumab vs. placebo after radical resection for high-risk muscle-invasive urothelial carcinoma: Results from the phase 3 checkmate 27... by Gschwend, J.E., Bajorin, D., Galsky, M., Broughton, E., Braverman, J., Koon, H., Maira-Arce, M., Hamilton, M., Shi, L., Guo, S., Witjes, J.A.

Get full text